BIO-TECHNE Corp SEC filings TECH
BIO-TECHNE Corp has 1,001 filings in SEC EDGAR's recent list, going back to Apr 29, 2008. Its latest annual report, Form 10-K, was filed on Aug 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 29, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2021 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 25, 2018 | — |
| UPLOAD | Letter from the SEC | May 1, 2018 | — |
| CORRESP | Letter to the SEC | Apr 5, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2018 | — |
| CORRESP | Letter to the SEC | Feb 23, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2018 | — |
| NT 10-K | Form nt 10-k | Aug 29, 2017 | Jun 30, 2017 |
| SD | Specialized disclosure (conflict minerals) | May 26, 2017 | — |
| UPLOAD | Letter from the SEC | May 16, 2017 | — |
| CORRESP | Letter to the SEC | May 5, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2017 | — |
| CORRESP | Letter to the SEC | Mar 23, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2010 | — |
| CORRESP | Letter to the SEC | Feb 9, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2010 | — |
| CORRESP | Letter to the SEC | Dec 29, 2009 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2009 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2008 | — |
| CORRESP | Letter to the SEC | Nov 14, 2008 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2008 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECH (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- MN
- Headquarters
- Minneapolis, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/ (until Oct 28, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.